CLINICAL AND TOXICOLOGICAL EVALUATION OF MS14 NATURAL PRODUCT IN PATIENTS WITH MULTIPLE SCLEROSIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NASERI M.; AHMADI A.; GHAREGOZLI KOUROUSH; NABAVI M.; FAGHIHZADEH S.; ASHTARIAN N.; MONTAZEMI F.; REZAEIZADEH H.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Daneshvar Medicine: Basic and Clinical Research Journal Year:2007 | Volume:14 | Issue:68 Page(s): 59-64

Download Full-Text

Persian Verion

View:

1,166

Download:

Cites:

Information Journal Paper

Title

CLINICAL AND TOXICOLOGICAL EVALUATION OF MS14 NATURAL PRODUCT IN PATIENTS WITH MULTIPLE SCLEROSIS

Author(s)

Keywords

TOXICOLOGYQ2

MULTIPLE SCLEROSISQ2

NATURAL PRODUCTQ3

Abstract

Introduction: MULTIPLE SCLEROSIS disease belonged to the demyelinazing diseases and one the most important by virtue of its frequency, chronicity and tendency to attack young adults. Current research into new drugs is focused on agents that will prevent, slow down and/or halt the progress of the disease process material, Methods.Materials & Methods: MS14 is a natural (herbal-marine) product which has been used for MULTIPLE SCLEROSIS disease based on anecdotal evidences. Pervious studies showed that MS14 had no sub acute toxicity in rat and had positive effect on quality of life in MS patients in pilot studies. The objective of this study was to assess the safety of MS14 using orally in patients with cerebella ataxic MULTIPLE SCLEROSIS, over the 3 weeks. The study was a placebo controlled, double blind, cross over clinical trial.Results: No significant changes were observed in vital signs, biochemical, hematological, liver function test, and kidney function test.

Cites

References

STUDY THE SUB ACUTE TOXICITY OF NATURAL PRODUCT MS14 IN RAT

Cite

APA: Copy

NASERI, M., AHMADI, A., GHAREGOZLI, KOUROUSH, NABAVI, M., FAGHIHZADEH, S., ASHTARIAN, N., MONTAZEMI, F., & REZAEIZADEH, H.. (2007). CLINICAL AND TOXICOLOGICAL EVALUATION OF MS14 NATURAL PRODUCT IN PATIENTS WITH MULTIPLE SCLEROSIS. DANESHVAR MEDICINE, 14(68), 59-64. SID. https://sid.ir/paper/31199/en

Vancouver: Copy

NASERI M., AHMADI A., GHAREGOZLI KOUROUSH, NABAVI M., FAGHIHZADEH S., ASHTARIAN N., MONTAZEMI F., REZAEIZADEH H.. CLINICAL AND TOXICOLOGICAL EVALUATION OF MS14 NATURAL PRODUCT IN PATIENTS WITH MULTIPLE SCLEROSIS. DANESHVAR MEDICINE[Internet]. 2007;14(68):59-64. Available from: https://sid.ir/paper/31199/en

IEEE: Copy

M. NASERI, A. AHMADI, KOUROUSH GHAREGOZLI, M. NABAVI, S. FAGHIHZADEH, N. ASHTARIAN, F. MONTAZEMI, and H. REZAEIZADEH, “CLINICAL AND TOXICOLOGICAL EVALUATION OF MS14 NATURAL PRODUCT IN PATIENTS WITH MULTIPLE SCLEROSIS,” DANESHVAR MEDICINE, vol. 14, no. 68, pp. 59–64, 2007, [Online]. Available: https://sid.ir/paper/31199/en

Related Journal Papers